The U.S. Food and Drug Administration is delaying by three months its decision on whether or not to approve tolebrutinib for ...
In this article, ACRO explores multiple sclerosis—a silent battle unfolding within the central nervous system.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback